Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Is there a prognostic indication for PTCA?]

M P Heintzen1, C J Michel, U E Heidland

  • 1Medizinische Klinik und Poliklinik B Kardiologie, Pneumologie und Angiologie Heinrich-Heine-Universität, Düsseldorf.

Zeitschrift Fur Kardiologie
|October 29, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Determinants of long-term follow-up after stent implantation in acute myocardial infarction].

Zeitschrift fur Kardiologie·2002
Same author

[Autonomic dysfunction in cardiopulmonary diseases].

Der Internist·2002
Same author

[Autonomic dysfunction in heart diseases and diabetes mellitus. Monitoring and diagnosis].

Der Internist·2002
Same author

Successful thrombolysis of st. Jude medical aortic prosthesis with tissue-type plasminogen activator in a pregnant woman: a case report.

Cardiology in review·2002
Same author

Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy.

Cardiology·2002
Same author

[Cardiological diagnosis in patients with obstructive sleep apnea].

Deutsche medizinische Wochenschrift (1946)·2002
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[On pathogenesis of coronary heart disease].

Zeitschrift fur Kardiologie·2016
Same journal

An overview of the evolution of the atherosclerotic plaque: from fatty streak to plaque rupture and thrombosis.

Zeitschrift fur Kardiologie·2016
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[Reconstructive surgery of the aortic root].

Zeitschrift fur Kardiologie·2016
See all related articles

Percutaneous coronary intervention (PCI) is typically for symptomatic patients with ischemia. For asymptomatic patients, "prognostic indication" for PCI lacks large-scale evidence, requiring careful risk assessment.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Medicine

Background:

  • Coronary angioplasty is indicated for symptomatic patients with significant coronary stenosis and myocardial ischemia.
  • Percutaneous Transluminal Coronary Angioplasty (PTCA) aims to alleviate symptoms and improve prognosis in these patients.
  • Coronary anatomy suitability is crucial for successful PTCA.

Purpose of the Study:

  • To define and evaluate the concept of "prognostic indication" for coronary angioplasty in asymptomatic patients.
  • To assess the current evidence and clinical considerations for using PTCA in asymptomatic individuals without proven ischemia.
  • To highlight the need for risk-benefit analysis in "prognostic indication" cases.

Main Methods:

  • Review of current clinical practice and literature regarding coronary angioplasty indications.

Related Experiment Videos

  • Analysis of the definition and application of "prognostic indication" in interventional cardiology.
  • Discussion of the evidence gap for PTCA in asymptomatic patients without ischemia.

    • Main Results:

    • "Prognostic indication" refers to interventional treatment of stenosis in asymptomatic patients without ischemia, aiming to improve prognosis.
    • Up to 20% of balloon angioplasty and 10% of stenting procedures may be performed under "prognostic indication".
    • No large-scale studies currently demonstrate a benefit of "prognostic indication" interventions in asymptomatic patients without ischemia.

    Conclusions:

    • While "prognostic indication" is used, robust evidence supporting its benefit in asymptomatic patients without ischemia is lacking.
    • Certain subgroups might benefit from PTCA under "prognostic indication" compared to medical therapy alone.
    • Careful consideration of individual coronary disease risk versus procedural risk is essential for patients treated with "prognostic indication".